An alternative pathway for gene regulation by Myc - PubMed (original) (raw)

An alternative pathway for gene regulation by Myc

K Peukert et al. EMBO J. 1997.

Abstract

The c-Myc protein activates transcription as part of a heteromeric complex with Max. However, Myc-transformed cells are characterized by loss of expression of several genes, suggesting that Myc may also repress gene expression. Two-hybrid cloning identifies a novel POZ domain Zn finger protein (Miz-1; Myc-interacting Zn finger protein-1) that specifically interacts with Myc, but not with Max or USF. Miz-1 binds to start sites of the adenovirus major late and cyclin D1 promoters and activates transcription from both promoters. Miz-1 has a potent growth arrest function. Binding of Myc to Miz-1 requires the helix-loop-helix domain of Myc and a short amphipathic helix located in the carboxy-terminus of Miz-1. Expression of Myc inhibits transactivation, overcomes Miz-1-induced growth arrest and renders Miz-1 insoluble in vivo. These processes depend on Myc and Miz-1 association and on the integrity of the POZ domain of Miz-1, suggesting that Myc binding activates a latent inhibitory function of this domain. Fusion of a nuclear localization signal induces efficient nuclear transport of Miz-1 and impairs the ability of Myc to overcome transcriptional activation and growth arrest by Miz-1. Our data suggest a model for how gene repression by Myc may occur in vivo.

PubMed Disclaimer

Cited by

The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides.
Daniel JM, Spring CM, Crawford HC, Reynolds AB, Baig A. Daniel JM, et al. Nucleic Acids Res. 2002 Jul 1;30(13):2911-9. doi: 10.1093/nar/gkf398. Nucleic Acids Res. 2002. PMID: 12087177 Free PMC article.
Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10.
Yang J, Hou C, Wang H, Perez EA, Do-Umehara HC, Dong H, Arunagiri V, Tong F, Van Scoyk M, Cho M, Liu X, Ge X, Winn RA, Ridge KM, Wang X, Chandel NS, Liu J. Yang J, et al. Cancer Lett. 2023 Feb 28;555:216025. doi: 10.1016/j.canlet.2022.216025. Epub 2022 Dec 17. Cancer Lett. 2023. PMID: 36538983 Free PMC article.
Miz1 is a signal- and pathway-specific modulator or regulator (SMOR) that suppresses TNF-alpha-induced JNK1 activation.
Liu J, Zhao Y, Eilers M, Lin A. Liu J, et al. Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18279-84. doi: 10.1073/pnas.0906328106. Epub 2009 Oct 7. Proc Natl Acad Sci U S A. 2009. PMID: 19815509 Free PMC article.
Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.
Salghetti SE, Kim SY, Tansey WP. Salghetti SE, et al. EMBO J. 1999 Feb 1;18(3):717-26. doi: 10.1093/emboj/18.3.717. EMBO J. 1999. PMID: 9927431 Free PMC article.
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S; Cancer Genome Atlas Research Network; Xie W, Yang D. Wang Z, et al. Cancer Cell. 2018 Apr 9;33(4):706-720.e9. doi: 10.1016/j.ccell.2018.03.006. Epub 2018 Apr 2. Cancer Cell. 2018. PMID: 29622465 Free PMC article.

References

1. Science. 1990 Nov 23;250(4984):1149-51 - PubMed
1. Science. 1991 Jan 11;251(4990):186-9 - PubMed
1. Mol Cell Biol. 1991 Apr;11(4):2291-5 - PubMed
1. Cell. 1991 May 3;65(3):395-407 - PubMed
1. Genes Dev. 1992 Feb;6(2):166-76 - PubMed

An alternative pathway for gene regulation by Myc - PubMed (original) (raw)